Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography

Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109-0028.

OBJECTIVE. The aim of this study was to determine the prognostic significance of perfusion-metabolism imaging in patients undergoing positron emission tomography for myocardial viability assessment. BACKGROUND. Positron emission tomography using nitrogen-13 ammonia and 18fluorodeoxyglucose to assess myocardial blood flow and metabolism has been shown to predict improvement in wall motion after coronary artery revascularization. The prognostic implications of metabolic imaging in patients with advanced coronary artery disease have not been investigated. METHODS. Eighty-two patients with advanced coronary artery disease and impaired left ventricular function underwent positron emission tomographic imaging between August 1988 and March 1990 to assess myocardial viability before coronary artery revascularization. RESULTS. Forty patients underwent successful revascularization. Patients who exhibited evidence of metabolically compromised myocardium by positron emission tomography (decreased blood flow with preserved metabolism) who did not undergo subsequent revascularization were more likely to experience a myocardial infarction, death, cardiac arrest or late revascularization due to development of new symptoms than were the other patient groups (p less than 0.01). Concordantly decreased flow and metabolism in segments of previous infarction did not affect outcome in patients with or without subsequent revascularization. Those with a compromised myocardium who did undergo revascularization were more likely to experience an improvement in functional class than were patients with preoperative positron emission tomographic findings of concordant decrease in flow and metabolism. CONCLUSIONS. Positron emission tomographic myocardial viability imaging appears to identify patients at increased risk of having an adverse cardiac event or death. Patients with impaired left ventricular function and positron emission tomographic evidence for jeopardized myocardium appear to have the most benefit from a revascularization procedure.

This article has been cited by other articles:

				G. D'Egidio, G. Nichol, K. A. Williams, A. Guo, L. Garrard, R. deKemp, T. D. Ruddy, J. DaSilva, D. Humen, K. Y. Gulenchyn, et al. Increasing Benefit From Revascularization Is Associated With Increasing Amounts of Myocardial Hibernation: A Substudy of the PARR-2 Trial J. Am. Coll. Cardiol. Img., September 1, 2009; 2(9): 1060 - 1068. [Abstract] [Full Text] [PDF]

				V Rizzello, D Poldermans, E Biagini, A F L Schinkel, E Boersma, A Boccanelli, T Marwick, J R T C Roelandt, and J J Bax Prognosis of patients with ischaemic cardiomyopathy after coronary revascularisation: relation to viability and improvement in left ventricular ejection fraction Heart, August 1, 2009; 95(15): 1273 - 1277. [Abstract] [Full Text] [PDF]

				S. H. Rahimtoola, V. Dilsizian, C. M. Kramer, T. H. Marwick, and J.-L. J. Vanoverschelde Chronic ischemic left ventricular dysfunction from pathophysiology to imaging and its integration into clinical practice. J. Am. Coll. Cardiol. Img., July 1, 2008; 1(4): 536 - 555. [Abstract] [Full Text] [PDF]

				K. H. Schuleri, L. C. Amado, A. J. Boyle, M. Centola, A. P. Saliaris, M. R. Gutman, K. E. Hatzistergos, B. N. Oskouei, J. M. Zimmet, R. G. Young, et al. Early improvement in cardiac tissue perfusion due to mesenchymal stem cells Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2002 - H2011. [Abstract] [Full Text] [PDF]

				R. S.B. Beanlands, G. Nichol, E. Huszti, D. Humen, N. Racine, M. Freeman, K. Y. Gulenchyn, L. Garrard, R. deKemp, A. Guo, et al. F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging-Assisted Management of Patients With Severe Left Ventricular Dysfunction and Suspected Coronary Disease: A Randomized, Controlled Trial (PARR-2) J. Am. Coll. Cardiol., November 13, 2007; 50(20): 2002 - 2012. [Abstract] [Full Text] [PDF]

				A. F.L. Schinkel, D. Poldermans, A. Elhendy, and J. J. Bax Assessment of Myocardial Viability in Patients with Heart Failure J. Nucl. Med., July 1, 2007; 48(7): 1135 - 1146. [Abstract] [Full Text] [PDF]

				R. Senior To revascularize or not to revascularize: a dilemma in heart failure. Can. Med. Assoc. J., August 15, 2006; 175(4): 372 - 372. [Full Text] [PDF]

				K. G. Tarakji, R. Brunken, P. M. McCarthy, M. O. Al-Chekakie, A. Abdel-Latif, C. E. Pothier, E. H. Blackstone, and M. S. Lauer Myocardial Viability Testing and the Effect of Early Intervention in Patients With Advanced Left Ventricular Systolic Dysfunction Circulation, January 17, 2006; 113(2): 230 - 237. [Abstract] [Full Text] [PDF]

				A. F.L. Schinkel, D. Poldermans, V. Rizzello, R. T. van Domburg, R. Valkema, A. Elhendy, E. Biagini, E. P. Krenning, M. L. Simoons, and J. J. Bax Impact of Diabetes Mellitus on Prediction of Clinical Outcome After Coronary Revascularization by 18F-FDG SPECT in Patients with Ischemic Left Ventricular Dysfunction J. Nucl. Med., January 1, 2006; 47(1): 68 - 73. [Abstract] [Full Text] [PDF]

				A. Desideri, L. Cortigiani, A. I. Christen, S. Coscarelli, D. Gregori, P. Zanco, R. Komorovsky, and J. J. Bax The Extent of Perfusion-F18-Fluorodeoxyglucose Positron Emission Tomography Mismatch Determines Mortality in Medically Treated Patients With Chronic Ischemic Left Ventricular Dysfunction J. Am. Coll. Cardiol., October 4, 2005; 46(7): 1264 - 1269. [Abstract] [Full Text] [PDF]

				M. A. Stankewicz, C. S. Mansour, R. L. Eisner, K. B. Churchwell, B. R. Williams, S. R. Sigman, J. Streeter, and R. E. Patterson Myocardial Viability Assessment by PET: 82Rb Defect Washout Does Not Predict the Results of Metabolic-Perfusion Mismatch J. Nucl. Med., October 1, 2005; 46(10): 1602 - 1609. [Abstract] [Full Text] [PDF]

				M. Schwaiger, S. Ziegler, and S. G. Nekolla PET/CT: Challenge for Nuclear Cardiology J. Nucl. Med., October 1, 2005; 46(10): 1664 - 1678. [Abstract] [Full Text] [PDF]

				P. Chareonthaitawee, B. J. Gersh, P. A. Araoz, and R. J. Gibbons Revascularization in Severe Left Ventricular Dysfunction: The Role of Viability Testing J. Am. Coll. Cardiol., August 16, 2005; 46(4): 567 - 574. [Abstract] [Full Text] [PDF]

				V Rizzello, D Poldermans, E Biagini, A F L Schinkel, R van Domburg, A Elhendy, E C Vourvouri, M Bountioukos, A Lombardo, B Krenning, et al. Improvement of stress LVEF rather than rest LVEF after coronary revascularisation in patients with ischaemic cardiomyopathy and viable myocardium Heart, March 1, 2005; 91(3): 319 - 323. [Abstract] [Full Text] [PDF]

				S. Graf, M. Gyongyosi, A. Khorsand, S. G. Nekolla, C. Pirich, K. Kletter, R. Dudczak, D. Glogar, G. Porenta, and H. Sochor Electromechanical Properties of Perfusion/Metabolism Mismatch: Comparison of Nonfluoroscopic Electroanatomic Mapping with 18F-FDG PET J. Nucl. Med., October 1, 2004; 45(10): 1611 - 1618. [Abstract] [Full Text] [PDF]

				J J Bax, E E van der Wall, and M Harbinson Radionuclide techniques for the assessment of myocardial viability and hibernation Heart, August 1, 2004; 90(suppl_5): v26 - v33. [Full Text] [PDF]

				S.R. Underwood, J. J Bax, J. v. Dahl, M. Y Henein, A. C van Rossum, E. R Schwarz, J.-L. Vanoverschelde, E. E.v. d. Wall, and W. Wijns Imaging techniques for the assessment of myocardial hibernation: Report of a Study Group of the European Society of Cardiology Eur. Heart J., May 2, 2004; 25(10): 815 - 836. [Abstract] [Full Text] [PDF]

				M Bountioukos, A F L Schinkel, J J Bax, V Rizzello, R Valkema, B J Krenning, E Biagini, E C Vourvouri, J R T C Roelandt, and D Poldermans Pulsed wave tissue Doppler imaging for the quantification of contractile reserve in stunned, hibernating, and scarred myocardium Heart, May 1, 2004; 90(5): 506 - 510. [Abstract] [Full Text] [PDF]

				K. L. Gould, H. Taegtmeyer, Z.-X. He, R.-F. Shi, Y.-J. Wu, Y.-Q. Tian, X.-J. Liu, X.-W. Qin, R.-L. Gao, S.-W. Wang, et al. Myocardial Ischemia, Fluorodeoxyglucose, and Severity of Coronary Artery Stenosis: The Complexities of Metabolic Remodeling in Hibernating Myocardium * Response Circulation, March 30, 2004; 109(12): e167 - e170. [Full Text] [PDF]

				K. Shan, G. Constantine, M. Sivananthan, and S. D. Flamm Role of Cardiac Magnetic Resonance Imaging in the Assessment of Myocardial Viability Circulation, March 23, 2004; 109(11): 1328 - 1334. [Full Text] [PDF]

				M. Bountioukos, A. F.L. Schinkel, D. Poldermans, V. Rizzello, E. C. Vourvouri, B. J. Krenning, E. Biagini, J. R.T.C. Roelandt, and J. J. Bax QT dispersion correlates to myocardial viability assessed by dobutamine stress echocardiography in patients with severely depressed left ventricular function due to coronary artery disease Eur J Heart Fail, March 1, 2004; 6(2): 187 - 193. [Abstract] [Full Text] [PDF]

				H. Yang, M. Pu, D. Rodriguez, D. Underwood, B. P. Griffin, V. Kalahasti, J. D. Thomas, and R. C. Brunken Ischemic and viable myocardium in patients with Non-Q-Wave or Q-Wave myocardial infarction and left ventricular dysfunction: A clinical study using positron emission tomography, echocardiography, and electrocardiography J. Am. Coll. Cardiol., February 18, 2004; 43(4): 592 - 598. [Abstract] [Full Text] [PDF]

				S. Sawada, A. Bapat, D. Vaz, J. Weksler, N. Fineberg, A. Greene, I. Gradus-Pizlo, and H. Feigenbaum Incremental value of myocardial viability for prediction of Long-Term prognosis in surgically revascularized patients with left ventricular dysfunction J. Am. Coll. Cardiol., December 17, 2003; 42(12): 2099 - 2105. [Abstract] [Full Text] [PDF]

				M Bountioukos, A F L Schinkel, J J Bax, V Rizzello, R Rambaldi, E C Vourvouri, J R T C Roelandt, and D Poldermans Quantification of regional left ventricular function in Q wave and non-Q wave dysfunctional regions by tissue Doppler imaging in patients with ischaemic cardiomyopathy Heart, November 1, 2003; 89(11): 1322 - 1326. [Abstract] [Full Text] [PDF]

				A. F.L. Schinkel, J. J. Bax, R. Valkema, A. Elhendy, R. T. van Domburg, E. C. Vourvouri, M. A. Bountioukos, E. P. Krenning, J. R.T.C. Roelandt, and D. Poldermans Effect of Diabetes Mellitus on Myocardial 18F-FDG SPECT Using Acipimox for the Assessment of Myocardial Viability J. Nucl. Med., June 1, 2003; 44(6): 877 - 883. [Abstract] [Full Text] [PDF]

				G. I.W. Galasko and A. Lahiri The non-invasive assessment of hibernating myocardium in ischaemic cardiomyopathy--a myriad of techniques Eur J Heart Fail, June 1, 2003; 5(3): 217 - 227. [Abstract] [Full Text] [PDF]

				G. Kleikamp, A. Maleszka, N. Reiss, B. Stuttgen, and R. Korfer Determinants of mid- and long-term results in patients after surgical revascularization for ischemic cardiomyopathy Ann. Thorac. Surg., May 1, 2003; 75(5): 1406 - 1412. [Abstract] [Full Text] [PDF]

				F. C. Visser Prediction of Surgical Treatment Effect by Preoperative Imaging:Present and Future Perspectives Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2003; 7(1): 31 - 36. [PDF]

				B. L.R. Kam, R. Valkema, D. Poldermans, J. J. Bax, A. E.M. Reijs, R. Rambaldi, E. Boersma, T. Rietveld, J. R.T.C. Roelandt, and E. P. Krenning Feasibility and Image Quality of Dual-Isotope SPECT Using 18F-FDG and 99mTc-Tetrofosmin After Acipimox Administration J. Nucl. Med., February 1, 2003; 44(2): 140 - 145. [Abstract] [Full Text] [PDF]

				J. Meluzin, J. Cerny, L. Spinarova, J. Toman, L. Groch, F. Stetka, M. Frelich, P. Hude, J. Krejci, L. Rambouskova, et al. Prognosis of patients with chronic coronary artery disease and severe left ventricular dysfunction. The importance of myocardial viability Eur J Heart Fail, January 1, 2003; 5(1): 85 - 93. [Abstract] [Full Text] [PDF]

				R. S. B. Beanlands, T. D. Ruddy, R. A. deKemp, R. M. Iwanochko, G. Coates, M. Freeman, C. Nahmias, P. Hendry, R. J. Burns, A. Lamy, et al. Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function J. Am. Coll. Cardiol., November 20, 2002; 40(10): 1735 - 1743. [Abstract] [Full Text] [PDF]

				K. C. Allman, L. J. Shaw, R. Hachamovitch, and J. E. Udelson Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis J. Am. Coll. Cardiol., April 3, 2002; 39(7): 1151 - 1158. [Abstract] [Full Text] [PDF]

				B. L. Gerber, S. Laycock, J. A. Melin, M. Borgers, W. Flameng, and J.-L. J. Vanoverschelde Myocardial Blood Flow, Metabolism, and Inotropic Reserve in Dogs with Dysfunctional Noninfarcted Collateral-Dependent Myocardium J. Nucl. Med., April 1, 2002; 43(4): 556 - 565. [Abstract] [Full Text] [PDF]

				K. F. Kofoed, R. Bangsgaard, S. Carstensen, J. H. Svendsen, P. R. Hansen, H. Arendrup, B. Hesse, and H. Kelbaek Prolonged ischemic heart disease and coronary artery bypass -- relation to contractile reserve Eur. J. Cardiothorac. Surg., March 1, 2002; 21(3): 417 - 423. [Abstract] [Full Text] [PDF]

				C. Klein, S. G. Nekolla, F. M. Bengel, M. Momose, A. Sammer, F. Haas, B. Schnackenburg, W. Delius, H. Mudra, D. Wolfram, et al. Assessment of Myocardial Viability With Contrast-Enhanced Magnetic Resonance Imaging: Comparison With Positron Emission Tomography Circulation, January 15, 2002; 105(2): 162 - 167. [Abstract] [Full Text] [PDF]

				G. D. Vitale, R. A. deKemp, T. D. Ruddy, K. Williams, and R. S.B. Beanlands Myocardial Glucose Utilization and Optimization of 18F-FDG PET Imaging in Patients with Non-Insulin-Dependent Diabetes Mellitus, Coronary Artery Disease, and Left Ventricular Dysfunction J. Nucl. Med., December 1, 2001; 42(12): 1730 - 1736. [Abstract] [Full Text] [PDF]

				B.L Gerber, F.F Ordoubadi, W Wijns, J.-L.J Vanoverschelde, M.J Knuuti, M Janier, P Melon, P.K Blanksma, A Bol, J.J Bax, et al. Positron emission tomography using18F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community Concerted Action Multicenter study on use of18F-fluoro-deoxyglucose Positron Emission Tomography for the Detection of Myocardial Viability Eur. Heart J., September 2, 2001; 22(18): 1691 - 1701. [Abstract] [PDF]

				J.J. Bax, A. Elhendy, E. Boersma, and D. Poldermans Evaluation of patients with chronic ischaemic left ventricular dysfunction - assessment of tissue viability Eur. Heart J. Suppl., September 1, 2001; 3(suppl_F): F11 - F14. [Abstract] [PDF]

				X. Zhang, X.-J. Liu, Q. Wu, R. Shi, R. Gao, Y. Liu, S. Hu, Y. Tian, S. Guo, and W. Fang Clinical Outcome of Patients with Previous Myocardial Infarction and Left Ventricular Dysfunction Assessed with Myocardial 99mTc-MIBI SPECT and 18F-FDG PET J. Nucl. Med., August 1, 2001; 42(8): 1166 - 1173. [Abstract] [Full Text] [PDF]

				J. S. Keppler and P. S. Conti A Cost Analysis of Positron Emission Tomography Am. J. Roentgenol., July 1, 2001; 177(1): 31 - 40. [Abstract] [Full Text] [PDF]

				J. A. Fallavollita, M. Logue, and J. M. Canty Jr. Stability of hibernating myocardium in pigs with a chronic left anterior descending coronary artery stenosis: absence of progressive fibrosis in the setting of stable reductions in flow, function and coronary flow reserve J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1989 - 1995. [Abstract] [Full Text] [PDF]

				R Sicari, A Ripoli, E Picano, A.C Borges, A Varga, W Mathias, L Cortigiani, R Bigi, J Heyman, S Polimeno, et al. The prognostic value of myocardial viability recognized by low dose dipyridamole echocardiography in patients with chronic ischaemic left ventricular dysfunction Eur. Heart J., May 2, 2001; 22(10): 837 - 844. [Abstract] [PDF]

				Y. Yong, S. F. Nagueh, S. Shimoni, K. Shan, Z.-X. He, M. J. Reardon, G. V. Letsou, J. F. Howell, M. S. Verani, M. A. Quinones, et al. Deceleration Time in Ischemic Cardiomyopathy : Relation to Echocardiographic and Scintigraphic Indices of Myocardial Viability and Functional Recovery After Revascularization Circulation, March 6, 2001; 103(9): 1232 - 1237. [Abstract] [Full Text] [PDF]

				H.-M. J. Siebelink, P. K. Blanksma, H. J. G. M. Crijns, J. J. Bax, A. J. van Boven, T. Kingma, D. A. Piers, J. Pruim, P. L. Jager, W. Vaalburg, et al. No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: A prospective, randomized comparison of patients with suspicion of jeopardized myocardium J. Am. Coll. Cardiol., January 1, 2001; 37(1): 81 - 88. [Abstract] [Full Text] [PDF]

				J. J. Bax, F. C. Visser, D. Poldermans, A. Elhendy, J. H. Cornel, E. Boersma, R. Valkema, A. van Lingen, P. M. Fioretti, and C. A. Visser Relationship Between Preoperative Viability and Postoperative Improvement in LVEF and Heart Failure Symptoms J. Nucl. Med., January 1, 2001; 42(1): 79 - 86. [Abstract] [Full Text] [PDF]

				R. Sciagra, M. Pellegri, A. Pupi, L. Bolognese, G. Bisi, V. Carnovale, and G. M. Santoro Prognostic implications of Tc-99m sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction J. Am. Coll. Cardiol., September 1, 2000; 36(3): 739 - 745. [Abstract] [Full Text] [PDF]

				P. R. Sensky, A. Jivan, N. M. Hudson, R. P. Keal, B. Morgan, J. L. Tranter, D. de Bono, N. J. Samani, and G. R. Cherryman Coronary Artery Disease: Combined Stress MR Imaging Protocol-One-Stop Evaluation of Myocardial Perfusion and Function Radiology, May 1, 2000; 215(2): 608 - 614. [Abstract] [Full Text]

				J. M. Cwajg, E. Cwajg, S. F. Nagueh, Z.-X. He, U. Qureshi, L. I. Olmos, M. A. Quinones, M. S. Verani, W. L. Winters, and W. A. Zoghbi End-diastolic wall thickness as a predictor of recovery of function in myocardial hibernation: Relation to rest-redistribution Tl-201 tomography and dobutamine stress echocardiography J. Am. Coll. Cardiol., April 1, 2000; 35(5): 1152 - 1161. [Abstract] [Full Text] [PDF]

				G. A. Beller and B. L. Zaret Contributions of Nuclear Cardiology to Diagnosis and Prognosis of Patients With Coronary Artery Disease Circulation, March 28, 2000; 101(12): 1465 - 1478. [Full Text] [PDF]

				R J Trent, G D Waiter, G S Hillis, F I McKiddie, T W Redpath, and S Walton Dobutamine magnetic resonance imaging as a predictor of myocardial functional recovery after revascularisation Heart, January 1, 2000; 83(1): 40 - 46. [Abstract] [Full Text] [PDF]

				T. Sharir, D. S. Berman, H. C. Lewin, J. D. Friedman, I. Cohen, R. Miranda, R. D. Agafitei, and G. Germano Incremental Prognostic Value of Rest-Redistribution 201Tl Single-Photon Emission Computed Tomography Circulation, November 9, 1999; 100(19): 1964 - 1970. [Abstract] [Full Text] [PDF]

				F. A. Chaudhry, J. T. Tauke, R. S. Alessandrini, G. Vardi, M. A. Parker, and R. O. Bonow Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction J. Am. Coll. Cardiol., September 1, 1999; 34(3): 730 - 738. [Abstract] [Full Text] [PDF]

				D. Pagano, P.G. Camici, and R.S. Bonser Revascularisation for chronic heart failure: a valid option? Eur J Heart Fail, August 31, 1999; 1(3): 269 - 273. [Full Text] [PDF]

				F Fath-Ordoubadi, K J Beatt, N Spyrou, and P G Camici Efficacy of coronary angioplasty for the treatment of hibernating myocardium Heart, August 1, 1999; 82(2): 210 - 216. [Abstract] [Full Text] [PDF]

				A. Pasquet, A. Robert, A.-M. D'Hondt, R. Dion, J. A. Melin, and J.-L. J. Vanoverschelde Prognostic Value of Myocardial Ischemia and Viability in Patients With Chronic Left Ventricular Ischemic Dysfunction Circulation, July 13, 1999; 100(2): 141 - 148. [Abstract] [Full Text] [PDF]

				M. A. Auerbach, H. Schoder, C. Hoh, S. S. Gambhir, S. Yaghoubi, J. W. Sayre, D. Silverman, M. E. Phelps, H. R. Schelbert, and J. Czernin Prevalence of Myocardial Viability as Detected by Positron Emission Tomography in Patients With Ischemic Cardiomyopathy Circulation, June 8, 1999; 99(22): 2921 - 2926. [Abstract] [Full Text] [PDF]

				R. W. Morse, S. Noe, J. Caravalho Jr., A. Balingit, and A. J. Taylor Rest-Redistribution 201Tl Single-Photon Emission CT Imaging for Determination of Myocardial Viability: Relationship Among Viability, Mode of Therapy, and Long-term Prognosis Chest, June 1, 1999; 115(6): 1621 - 1626. [Abstract] [Full Text] [PDF]

				H. Schoder, R. Campisi, T. Ohtake, C. K. Hoh, D. H. Moon, J. Czernin, and H. R. Schelbert Blood flow-metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1328 - 1337. [Abstract] [Full Text] [PDF]

				S. C. Smart, P. N. Dionisopoulos, T. A. Knickelbine, T. Schuchard, and K. B. Sagar Dobutamine-atropine stress echocardiography for risk stratification in patients with chronic left ventricular dysfunction J. Am. Coll. Cardiol., February 1, 1999; 33(2): 512 - 521. [Abstract] [Full Text] [PDF]

				S. WALTON Radionuclide techniques for myocardial viability and hibernation Heart, January 1, 1999; 81(1): 6 - 7. [Full Text]

				M. F. Di Carli, J. Maddahi, S. Rokhsar, H. R. Schelbert, D. Bianco-Batlles, R. C. Brunken, and B. Fromm LONG-TERM SURVIVAL OF PATIENTS WITH CORONARY ARTERY DISEASE AND LEFT VENTRICULAR DYSFUNCTION: IMPLICATIONS FOR THE ROLE OF MYOCARDIAL VIABILITY ASSESSMENT IN MANAGEMENT DECISIONS J. Thorac. Cardiovasc. Surg., December 1, 1998; 116(6): 997 - 1004. [Abstract] [Full Text] [PDF]

				A Al-Mohammad, I R Mahy, M Y Norton, G Hillis, J C Patel, P Mikecz, and S Walton Prevalence of hibernating myocardium in patients with severely impaired ischaemic left ventricles Heart, December 1, 1998; 80(6): 559 - 564. [Abstract] [Full Text]

				E. O. McFalls and H. B. Ward Flow-Metabolism Mismatch and Severe Ischemic Cardiomyopathy Circulation, November 17, 1998; 98(20): 2218 - 2218. [Full Text] [PDF]

				J. Meluzin, J. Cerny, M. Frelich, F. Stetka, L. Spinarova, J. Popelova, R. Stipal, and on behalf of the Investigators of This Multicenter Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction J. Am. Coll. Cardiol., October 1, 1998; 32(4): 912 - 920. [Abstract] [Full Text] [PDF]

				I. Afridi, P. A. Grayburn, J. A. Panza, J. K. Oh, W. A. Zoghbi, and T. H. Marwick Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction J. Am. Coll. Cardiol., October 1, 1998; 32(4): 921 - 926. [Abstract] [Full Text] [PDF]

				G. HEUSCH Hibernating Myocardium Physiol Rev, October 1, 1998; 78(4): 1055 - 1085. [Abstract] [Full Text] [PDF]

				E. Picano, R. Sicari, P. Landi, L. Cortigiani, R. Bigi, C. Coletta, A. Galati, J. Heyman, R. Mattioli, M. Previtali, et al. Prognostic Value of Myocardial Viability in Medically Treated Patients With Global Left Ventricular Dysfunction Early After an Acute Uncomplicated Myocardial Infarction : A Dobutamine Stress Echocardiographic Study Circulation, September 15, 1998; 98(11): 1078 - 1084. [Abstract] [Full Text] [PDF]

				M. Previtali, R. Fetiveau, L. Lanzarini, C. Cavalotti, and C. Klersy Prognostic value of myocardial viability and ischemia detected by dobutamine stress echocardiography early after acute myocardial infarction treated with thrombolysis J. Am. Coll. Cardiol., August 1, 1998; 32(2): 380 - 386. [Abstract] [Full Text] [PDF]

				W. Wijns, S. F. Vatner, and P. G. Camici Hibernating Myocardium N. Engl. J. Med., July 16, 1998; 339(3): 173 - 181. [Full Text] [PDF]

				J. E. Udelson Steps Forward in the Assessment of Myocardial Viability in Left Ventricular Dysfunction Circulation, March 10, 1998; 97(9): 833 - 838. [Full Text] [PDF]

				G. Srinivasan, A. N. Kitsiou, S. L. Bacharach, M. L. Bartlett, C. Miller-Davis, and V. Dilsizian [18F]Fluorodeoxyglucose Single Photon Emission Computed Tomography : Can It Replace PET and Thallium SPECT for the Assessment of Myocardial Viability? Circulation, March 10, 1998; 97(9): 843 - 850. [Abstract] [Full Text] [PDF]

				D Pagano, R S Bonser, J N Townend, F Ordoubadi, R Lorenzoni, and P G Camici Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure Heart, March 1, 1998; 79(3): 281 - 288. [Abstract] [Full Text]

				R. R. Kaprielian, M. Gunning, E. Dupont, M. N. Sheppard, S. M. Rothery, R. Underwood, D. J. Pennell, K. Fox, J. Pepper, P. A. Poole-Wilson, et al. Downregulation of Immunodetectable Connexin43 and Decreased Gap Junction Size in the Pathogenesis of Chronic Hibernation in the Human Left Ventricle Circulation, February 24, 1998; 97(7): 651 - 660. [Abstract] [Full Text] [PDF]

				M. Gheorghiade and R. O. Bonow Chronic Heart Failure in the United States : A Manifestation of Coronary Artery Disease Circulation, January 27, 1998; 97(3): 282 - 289. [Full Text] [PDF]

				H. H. Lee, V. G. Davila-Roman, P. A. Ludbrook, M. Courtois, J. F. Walsh, D. A. Delano, P. J. Rubin, and R. J. Gropler Dependency of Contractile Reserve on Myocardial Blood Flow : Implications for the Assessment of Myocardial Viability With Dobutamine Stress Echocardiography Circulation, November 4, 1997; 96(9): 2884 - 2891. [Abstract] [Full Text]

				G. Kleikamp, H. Posival, K. Minami, A. El-Banayosy, and R. Korfer Ischemic cardiomyopathy -- revascularization vs. transplantation Eur. J. Cardiothorac. Surg., April 1, 1997; 11(suppl): S1 - S4. [Abstract] [PDF]

				S. C. Smart, T. Knickelbine, T. R. Stoiber, M. Carlos, J. C. Wynsen, and K. B. Sagar Safety and Accuracy of Dobutamine-Atropine Stress Echocardiography for the Detection of Residual Stenosis of the Infarct-Related Artery and Multivessel Disease During the First Week After Acute Myocardial Infarction Circulation, March 18, 1997; 95(6): 1394 - 1401. [Abstract] [Full Text]

				M. E. Carlos, S. C. Smart, J. C. Wynsen, and K. B. Sagar Dobutamine Stress Echocardiography for Risk Stratification After Myocardial Infarction Circulation, March 18, 1997; 95(6): 1402 - 1410. [Abstract] [Full Text]

				R. O. Bonow Identification of Viable Myocardium Circulation, December 1, 1996; 94(11): 2674 - 2680. [Full Text]

				G. A. Beller Comparison of 201Tl Scintigraphy and Low-Dose Dobutamine Echocardiography for the Noninvasive Assessment of Myocardial Viability Circulation, December 1, 1996; 94(11): 2681 - 2684. [Full Text]

				B. Shivalkar, A. Maes, M. Borgers, J. Ausma, I. Scheys, J. Nuyts, L. Mortelmans, and W. Flameng Only Hibernating Myocardium Invariably Shows Early Recovery After Coronary Revascularization Circulation, August 1, 1996; 94(3): 308 - 315. [Abstract] [Full Text]

				J. vom Dahl, O. Muzik, E. R. Wolfe Jr, C. Allman, G. Hutchins, and M. Schwaiger Myocardial Rubidium-82 Tissue Kinetics Assessed by Dynamic Positron Emission Tomography as a Marker of Myocardial Cell Membrane Integrity and Viability Circulation, January 15, 1996; 93(2): 238 - 245. [Abstract] [Full Text]

				M. F. Di Carli, F. Asgarzadie, H. R. Schelbert, R. C. Brunken, H. Laks, M. E. Phelps, and J. Maddahi Quantitative Relation Between Myocardial Viability and Improvement in Heart Failure Symptoms After Revascularization in Patients With Ischemic Cardiomyopathy Circulation, December 15, 1995; 92(12): 3436 - 3444. [Abstract] [Full Text]

				M.G. Niemeyer, E.E. van der Wall, A.F.M. Kuijper, A.T. Cleophas, and E.K.J. Pauwels Nuclear Cardiology, Current Applications in Clinical Practice Angiology, July 1, 1995; 46(7): 591 - 602. [Abstract] [PDF]

				I. Afridi, N. S. Kleiman, A. E. Raizner, and W. A. Zoghbi Dobutamine Echocardiography in Myocardial Hibernation : Optimal Dose and Accuracy in Predicting Recovery of Ventricular Function After Coronary Angioplasty Circulation, February 1, 1995; 91(3): 663 - 670. [Abstract] [Full Text]